7 results
SC TO-T/A
EX-99
LLY
Lilly(Eli) & Co
15 Nov 23
Third party tender offer statement (amended)
6:51am
INDIANAPOLIS, Nov. 14, 2023 – Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Nuclear Regulatory Commission (“NRC”) has issued its
SC TO-T
EX-99
PNT
POINT Biopharma Global Inc.
13 Oct 23
Third party tender offer statement
6:52am
.
On September 15, 2023, representatives of Skadden, Kirkland & Ellis and Balch & Bingham LLP, POINT’s outside legal advisor specializing in nuclear law … , had a meeting by teleconference to discuss the process for obtaining consent from the Nuclear Regulatory Commission to transfer POINT’s materials
SC TO-C
EX-99.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Information about tender offer
4:30pm
common stock, and license transfer approval from the U.S. Nuclear Regulatory Commission. Following the successful closing of the tender offer, Lilly
8-K
EX-2.1
LLY
Lilly(Eli) & Co
10 Oct 08
Tender and Support Agreement
12:00am
products; radioactive material, including, without limitation, any source, special nuclear, or by-product material, as defined in 42 U.S.C. §2011 et seq
S-4/A
o8pl3tr
26 Oct 95
Registration of securities issued in business combination transactions (amended)
12:00am
S-4
m9thz4eq7 8n8vhdv4
13 Sep 95
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next